Unsaturated FAs and derivatives provided by the diet, de novo lipogenesis, and triglyceride lipolysis are natural PPAR ligands that enhance insulin sensitivity and reduce hepatic steatosis and lipogenesis. The gene discussed is INS; the disease is fatty liver disease.